Bernard Jacques Alex Gilly is a French entrepreneur and businessperson who founded 12 companies, notably: Gensight Biologics SA, Pixium Vision SA and CareX SA and who has been at the helm of 17 different companies. Presently, he holds the position of Independent Chairman of Eye Tech Care SA, Chairman at Pixium Vision SA (which he founded in 2011), Chairman for Prophesee SA (which he founded in 2014), Chairman of iBionext SAS (which he founded in 2015), Chairman & President at Brainever SAS, Chairman of Chronolife SAS, Chairman at Tilak Healthcare SAS (which he founded), Chairman for Brainiac SAS (which he founded) and Chief Executive Officer & Director at Gensight Biologics SA (which he founded in 2012).
He is also on the board of PX Therapeutics SA and T-Heart SAS.
In the past Dr. Gilly held the position of Chairman at Enterome SA, Non-Executive Chairman of Tissium SA (he founded the company in 2013), Chairman & Chief Executive Officer at Kutexis, President at Passage De L'Innovation, Vice President-Research & Development at Pasteur Mérieux Connaught, Partner at Sofinnova Partners SAS, Chairman of CareX SA (he founded the company), Chairman & Chief Executive Officer for Fovea Pharmaceuticals SA (he founded the company in 2005), President & Chief Executive Officer at Transgene SA, Executive Vice President-Ophthalmology Division at Sanofi Pasteur SA, Vice President-Research & Development of bioMérieux SA, Member-Executive Board at Cellzome AG (he founded the company in 2000) and Director at Domain Therapeutics SA.
Dr. Gilly received an MBA from INSEAD, a doctorate from the University of Rennes, a doctorate from the University of Rhode Island and an undergraduate degree from Ecole Nationale Supérieure Agronomique.